ASH: InnoCare Upbeat About BCL2 Inhibitor Mesutoclax In MCL

With China Pivotal Trial Data Expected in 2026

 
• By Xu Hu
  
The 67th American Society of Hematology (ASH) congress takes place in Orlando, Florida. (Shutterstock)

More from ASH

More from Conferences